Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 CIR Director Andersen To Be Honored by FDLI - Happi
Company News

CIR Director Andersen To Be Honored by FDLI

Food and Drug Law Institute recognizes service, leadership.

When the Food and Drug Law Institute (FDLI) presents its Distinguished Service and Leadership Award tomorrow at The Westin Georgetown in Washington, DC, F. Alan Andersen director, Cosmetic Ingredient Review (CIR), will be among the four recipients.



Andersen is also president of the FDA Alumni Association.


The awards recognize individuals from various areas of the food and drug law community for their notable service and leadership.


Prior to joining CIR in 1993, Anderson worked for 22 years in FDA’s radiological health/medical devices area, conducting research and later directing the device standards program, the research and testing laboratories and the device evaluation office. He has chaired the ANSI Medical Device Standards Board, and is past president of the clinical lab standards group. At FDA, he received the PHS Superior Service Award, the FDA Award of Merit, an Employees EEO Recognition Award, and has since received the FDA Distinguished Alumni Award and has been made a Penn State Alumni Fellow. Dr. Anderson received his BS from Muhlenberg College and his MS and PhD from Penn State.

FDLI, founded in 1949, is a non-profit organization that provides a marketplace for discussing food and drug law issues through conferences, publications and member interaction. FDLI’s scope includes food, drugs, animal drugs, biologics, cosmetics, diagnostics, dietary supplements, medical devices and tobacco.


Also to be presented with honors are Deborah M. Autor, deputy commissioner for Global Regulatory Operations and Policy, Food and Drug Administration; Robert P. Brady, Partner, Hogan Lovells; and Eugene M. Thirolf, Jr., a consultant.

Add us as a preferred source on Google

Get the latest Happi news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Happi Newsletters